The dsNKG2D-IL-21 nanoparticles preferentially amassed in the tumor cells which could subsequently continue to secrete the dsNKG2D-IL-21 protein, further activating T and NK cells against the tumor tissue. This evidence concerns the gene IL21 and neoplasm.